Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Wattie

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Calcified Tissue International|June 1, 1995
Ototoxicity associated with intravenous bisphosphonate administrationI R Reid, D A Mills, D J Wattie
The Journal of Clinical Endocrinology and Metabolism|June 1, 1991
The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal womenI R Reid, M C Evans, R Ames, et al.
Archives of Internal Medicine|June 10, 1996
Testosterone therapy in glucocorticoid-treated menI R Reid, D J Wattie, M C Evans, et al.
Clinical Endocrinology|September 1, 1992
Post-pregnancy osteoporosis associated with hypercalcaemiaI R Reid, D J Wattie, M C Evans, et al.
Clinical Endocrinology|January 1, 1997
Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosisB Orr-Walker, D J Wattie, M C Evans, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 1, 1992
Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patientsI R Reid, M C Evans, D J Wattie, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosisI R Reid, D J Wattie, M C Evans, et al.
Australian and New Zealand Journal of Medicine|December 1, 1984
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate)T R Fraser, H K Ibbertson, I M Holdaway, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 16, 2012
The impact of dietary calcium intake and vitamin D status on the effects of zoledronateS Bourke, M J Bolland, A Grey, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Calcified Tissue International|June 1, 1995
Ototoxicity associated with intravenous bisphosphonate administrationI R Reid, D A Mills, D J Wattie
The Journal of Clinical Endocrinology and Metabolism|June 1, 1991
The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal womenI R Reid, M C Evans, R Ames, et al.
Archives of Internal Medicine|June 10, 1996
Testosterone therapy in glucocorticoid-treated menI R Reid, D J Wattie, M C Evans, et al.
Clinical Endocrinology|September 1, 1992
Post-pregnancy osteoporosis associated with hypercalcaemiaI R Reid, D J Wattie, M C Evans, et al.
Clinical Endocrinology|January 1, 1997
Effects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosisB Orr-Walker, D J Wattie, M C Evans, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 1, 1992
Bone mineral density of the proximal femur and lumbar spine in glucocorticoid-treated asthmatic patientsI R Reid, M C Evans, D J Wattie, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1994
Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosisI R Reid, D J Wattie, M C Evans, et al.
Australian and New Zealand Journal of Medicine|December 1, 1984
Effective oral treatment of severe Paget's disease of bone with APD (3-amino-1-hydroxypropylidene-1,1-bisphosphonate); a comparison with combined calcitonin + EHDP (1-hydroxyethylidene-1,1-bisphosphonate)T R Fraser, H K Ibbertson, I M Holdaway, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 16, 2012
The impact of dietary calcium intake and vitamin D status on the effects of zoledronateS Bourke, M J Bolland, A Grey, et al.
Pageof 1